Updated Jul 16, 2026 · Last SEC filing 2026-06-24
10x Genomics, Inc. (TXG) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-24. 2 Form 8-K material event filings were reported by TXG in the last 90 days. 5 Form 144 notices of proposed sale were filed for TXG stock. InsiderAlpha tracks every TXG SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001770787 |
|---|
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 5 |
| Latest Form 4 filing | 2026-06-24 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Saxonov Serge | Chief Executive Officer | S — Open-market sale | 10.0K | $34.28 | $343K | SEC | |
| Saxonov Serge | Chief Executive Officer | S — Open-market sale | 9.8K | $35.32 | $347K | SEC | |
| Saxonov Serge | Chief Executive Officer | S — Open-market sale | 1.7K | $36.16 | $60K | SEC | |
| Saxonov Serge | Chief Executive Officer | S — Open-market sale | 8.5K | $33.29 | $284K | SEC | |
| SULIMAN SHEHNAAZ | Insider | S — Open-market sale | 5.4K | $32.59 | $175K | SEC | |
| SULIMAN SHEHNAAZ | Insider | S — Open-market sale | 364 | $33.27 | $12K | SEC | |
| STUELPNAGEL JOHN R | Insider | A — Grant or award | 8.8K | $0.00 | — | SEC | |
| SULIMAN SHEHNAAZ | Insider | A — Grant or award | 8.8K | $0.00 | — | SEC | |
| Teichmann Sarah A. | Insider | A — Grant or award | 8.8K | $0.00 | — | SEC | |
| Popovits Kimberly J | Insider | A — Grant or award | 8.8K | $0.00 | — | SEC | |
| MATEO ALAN | Insider | A — Grant or award | 8.8K | $0.00 | — | SEC | |
| Kosaraju Sridhar | Insider | A — Grant or award | 8.8K | $0.00 | — | SEC | |
| Saxonov Serge | Chief Executive Officer | S — Open-market sale | 10.7K | $24.71 | $265K | SEC | |
| Taich Adam | Chief Financial Officer | S — Open-market sale | 15.1K | $24.44 | $369K | SEC | |
| Hindson Benjamin J. | See Remarks | S — Open-market sale | 11.6K | $24.44 | $283K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for 10x Genomics, Inc. (TXG). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Saxonov Serge | 6 | $1.74M |
| SULIMAN SHEHNAAZ | 3 | $187K |
| Taich Adam | 1 | $369K |
| STUELPNAGEL JOHN R | 1 | — |
| Kosaraju Sridhar | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TXG insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live TXG dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.